Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,072 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score.
Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, Nakasone H. Okada Y, et al. Among authors: uehara y. Blood Adv. 2024 Mar 26;8(6):1359-1368. doi: 10.1182/bloodadvances.2023011837. Blood Adv. 2024. PMID: 38163321 Free PMC article.
Identification of unipotent megakaryocyte progenitors in human hematopoiesis.
Miyawaki K, Iwasaki H, Jiromaru T, Kusumoto H, Yurino A, Sugio T, Uehara Y, Odawara J, Daitoku S, Kunisaki Y, Mori Y, Arinobu Y, Tsuzuki H, Kikushige Y, Iino T, Kato K, Takenaka K, Miyamoto T, Maeda T, Akashi K. Miyawaki K, et al. Among authors: uehara y. Blood. 2017 Jun 22;129(25):3332-3343. doi: 10.1182/blood-2016-09-741611. Epub 2017 Mar 23. Blood. 2017. PMID: 28336526 Free article.
Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics.
Yamasaki S, Mizuno S, Iwasaki M, Seo S, Uchida N, Shigesaburo M, Nakano N, Ishiwata K, Uehara Y, Eto T, Takase K, Kawakita T, Tanaka M, Sawa M, Katayama Y, Nawa Y, Makoto O, Ichinohe T, Atsuta Y, Kanda J, Yanada M. Yamasaki S, et al. Among authors: uehara y. Ann Hematol. 2023 Jun;102(6):1549-1559. doi: 10.1007/s00277-023-05243-0. Epub 2023 May 1. Ann Hematol. 2023. PMID: 37126115
Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry.
Koresawa-Shimizu R, Suzuki R, Uehara Y, Hiramoto N, Sawa M, Fukuda T, Kataoka K, Kanda Y, Oyake T, Kubota Y, Uchida N, Yano S, Kobayashi H, Tanaka J, Atsuta Y, Kondo E. Koresawa-Shimizu R, et al. Among authors: uehara y. Bone Marrow Transplant. 2024 Jan;59(1):125-127. doi: 10.1038/s41409-023-02118-w. Epub 2023 Oct 7. Bone Marrow Transplant. 2024. PMID: 37805626 No abstract available.
Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma.
Kato K, Sugio T, Ikeda T, Yoshitsugu K, Miyazaki K, Suzumiya J, Yamamoto G, Kim SW, Ikegame K, Uehara Y, Mori Y, Ishikawa J, Hiramoto N, Eto T, Nakazawa H, Kobayashi H, Serizawa K, Onizuka M, Fukuda T, Atsuta Y, Suzuki R. Kato K, et al. Among authors: uehara y. Bone Marrow Transplant. 2024 Mar;59(3):306-314. doi: 10.1038/s41409-023-02156-4. Epub 2023 Dec 15. Bone Marrow Transplant. 2024. PMID: 38102209
Scoring system for optimal cord blood unit selection for single cord blood transplantation.
Watanabe M, Konuma T, Imahashi N, Terakura S, Seo S, Morishima S, Uchida N, Doki N, Tanaka M, Nishida T, Kawakita T, Eto T, Takahashi S, Sawa M, Uehara Y, Kim SW, Ishimaru F, Ichinohe T, Fukuda T, Atsuta Y, Kanda J. Watanabe M, et al. Among authors: uehara y. Cytotherapy. 2024 Mar;26(3):286-298. doi: 10.1016/j.jcyt.2023.12.001. Epub 2023 Dec 27. Cytotherapy. 2024. PMID: 38149949
A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis.
Kim H, Mizuno K, Masuda K, Sakurai M, Ara T, Naito K, Uehara Y, Yamamoto G, Osada M, Machida S, Horio T, Fukushima K, Mori Y, Ichinohe T, Fukuda T, Atsuta Y, Kataoka K. Kim H, et al. Among authors: uehara y. Transplant Cell Ther. 2024 Apr;30(4):419.e1-419.e12. doi: 10.1016/j.jtct.2024.01.071. Epub 2024 Jan 22. Transplant Cell Ther. 2024. PMID: 38266963
Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation.
Kuwatsuka Y, Kasajima R, Yamaguchi R, Uchida N, Konuma T, Tanaka M, Shingai N, Miyakoshi S, Kozai Y, Uehara Y, Eto T, Toyosaki M, Nishida T, Ishimaru F, Kato K, Fukuda T, Imoto S, Atsuta Y, Takahashi S. Kuwatsuka Y, et al. Among authors: uehara y. Transplant Cell Ther. 2024 Apr;30(4):444.e1-444.e11. doi: 10.1016/j.jtct.2024.02.001. Epub 2024 Feb 7. Transplant Cell Ther. 2024. PMID: 38336299
Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis.
Sakatoku K, Murata M, Shimazu Y, Uchida N, Yoshihara S, Uehara Y, Takahashi S, Kobayashi H, Tanaka H, Nakano N, Ishimaru F, Ichinohe T, Atsuta Y, Nagamura-Inoue T, Nakamae H. Sakatoku K, et al. Among authors: uehara y. Bone Marrow Transplant. 2024 May;59(5):705-707. doi: 10.1038/s41409-024-02244-z. Epub 2024 Feb 20. Bone Marrow Transplant. 2024. PMID: 38378917 No abstract available.
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy.
Itonaga H, Miyazaki Y, Fujioka M, Aoki J, Doki N, Nishida T, Fukuda T, Uchida N, Ueda Y, Uehara Y, Katayama Y, Ota S, Kawakita T, Kato J, Matsuoka KI, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Ishiyama K. Itonaga H, et al. Among authors: uehara y. Bone Marrow Transplant. 2024 May 7. doi: 10.1038/s41409-024-02297-0. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38714756
1,072 results